Journal Articles Conference Presentations Book Chapters Public Presentations

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.

Alton EW, Boyd AC, Cheng SH, Cunningham S, Davies JC, Gill DR, Griesenbach U, Higgins T, Hyde SC, Innes JA, Murray GD, Porteous DJ

Thorax

Thorax. 2013 Nov;68(11):1075-7. doi: 10.1136/thoraxjnl-2013-203309. Epub 2013 Mar 22.

Print this page

The UK Cystic Fibrosis Gene Therapy Consortium has been working towards clinical gene therapy for patients with cystic fibrosis for several years. We have recently embarked on a large, multi-dose clinical trial of a non-viral, liposome-based formulation powered for the first time to detect clinical benefit. The article describes the details of the protocol. KEYWORDS: Cystic Fibrosis

Go Back to Publications     View on Pubmed (23525080)    View on Google Scholar


 

Other Publications by these authors
Lung clearance index in primary ciliary dyskinesia and bronchiectasis.
Irving SJ et al. American Journal Of Respiratory And Critical Care Medicine (2014) Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
Alton EW et al. Gene Therapy (2013) The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
Alton EW et al. Biomaterials (2013) Expert opinion in biological therapy: update on developments in lung gene transfer.
Griesenbach U et al. Expert Opinion On Biological Therapy (2013) Oral contraceptives do not appear to affect cystic fibrosis disease severity.
Kernan NG et al. The European Respiratory Journal (2012) Progress in gene and cell therapy for cystic fibrosis lung disease.
Griesenbach U et al. Current Pharmaceutical Design (2012)